These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 18178333)

  • 1. Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding.
    Cani PD; Delzenne NM; Amar J; Burcelin R
    Pathol Biol (Paris); 2008 Jul; 56(5):305-9. PubMed ID: 18178333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microflora as a target for energy and metabolic homeostasis.
    Cani PD; Delzenne NM
    Curr Opin Clin Nutr Metab Care; 2007 Nov; 10(6):729-34. PubMed ID: 18089955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
    Diamant M; Blaak EE; de Vos WM
    Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gut microflora is a key player in host energy homeostasis].
    Delzenne NM; Cani PD
    Med Sci (Paris); 2008 May; 24(5):505-10. PubMed ID: 18466728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
    Esteve E; Ricart W; Fernández-Real JM
    Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.
    Cani PD; Bibiloni R; Knauf C; Waget A; Neyrinck AM; Delzenne NM; Burcelin R
    Diabetes; 2008 Jun; 57(6):1470-81. PubMed ID: 18305141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and the human microbiome.
    Ley RE
    Curr Opin Gastroenterol; 2010 Jan; 26(1):5-11. PubMed ID: 19901833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut microbiota, obesity and insulin resistance.
    Shen J; Obin MS; Zhao L
    Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota.
    Cani PD; Delzenne NM
    Curr Opin Pharmacol; 2009 Dec; 9(6):737-43. PubMed ID: 19628432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders.
    Neyrinck AM; Delzenne NM
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):722-8. PubMed ID: 20823777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal microbiota and obesity.
    Blaut M; Klaus S
    Handb Exp Pharmacol; 2012; (209):251-73. PubMed ID: 22249818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic endotoxemia initiates obesity and insulin resistance.
    Cani PD; Amar J; Iglesias MA; Poggi M; Knauf C; Bastelica D; Neyrinck AM; Fava F; Tuohy KM; Chabo C; Waget A; Delmée E; Cousin B; Sulpice T; Chamontin B; Ferrières J; Tanti JF; Gibson GR; Casteilla L; Delzenne NM; Alessi MC; Burcelin R
    Diabetes; 2007 Jul; 56(7):1761-72. PubMed ID: 17456850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity: genes, brain, gut, and environment.
    Das UN
    Nutrition; 2010 May; 26(5):459-73. PubMed ID: 20022465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota and its possible relationship with obesity.
    DiBaise JK; Zhang H; Crowell MD; Krajmalnik-Brown R; Decker GA; Rittmann BE
    Mayo Clin Proc; 2008 Apr; 83(4):460-9. PubMed ID: 18380992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal microbiota in inflammation and insulin resistance: relevance to humans.
    De Bandt JP; Waligora-Dupriet AJ; Butel MJ
    Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):334-40. PubMed ID: 21587065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity, metabolic syndrome, and microbiota: multiple interactions.
    Tilg H
    J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S16-8. PubMed ID: 20535027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice.
    Membrez M; Blancher F; Jaquet M; Bibiloni R; Cani PD; Burcelin RG; Corthesy I; Macé K; Chou CJ
    FASEB J; 2008 Jul; 22(7):2416-26. PubMed ID: 18326786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microecology, obesity, and probiotics.
    Tennyson CA; Friedman G
    Curr Opin Endocrinol Diabetes Obes; 2008 Oct; 15(5):422-7. PubMed ID: 18769213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The association of intestinal microbiota with obesity].
    Morales P; Brignardello J; Gotteland M
    Rev Med Chil; 2010 Aug; 138(8):1020-7. PubMed ID: 21140062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The normal intestinal microbiota.
    Marchesi J; Shanahan F
    Curr Opin Infect Dis; 2007 Oct; 20(5):508-13. PubMed ID: 17762785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.